Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Aug 2014

Levin Albert M, Lindquist Karla J, Avila Andrew, Witte John S, Paris Pamela L, Rybicki Benjamin A

Abstract excerpt

Evaluation of prostate cancer prognosis after surgery is increasingly relying upon genomic analyses of tumor DNA. We assessed the ability of the biomarker panel Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) to predict biochemical recurrence in 33 European American and 28 African American prostate cancer cases using genome-wide copy number data from a previous study. "Biomarker positive" was defined as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Dosage

Share to Genomics

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 24891551
DOI: 10.1158/1055-9965.EPI-13-1124
PMCID: PMC4119547

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of the Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) tumor biomarker for identifying recurrent disease in African American patients.PMID 24891551Read ↗

Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American MenSemantic proximity Read ↗

Racial Disparity in Utilizing Genetic Testing for Personalized Care of Prostate CancerSemantic proximity Read ↗

Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patientsSemantic proximity Read ↗

Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.Semantic proximity Read ↗

Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease RecurrenceSemantic proximity Read ↗

Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsSemantic proximity Read ↗

Precision medicine targets for prostate cancers in African American menSemantic proximity Read ↗

"Unveiling Prostate Cancer’s Molecular Tapestry: Ethnic Disparities and Prognostic Insights from Whole-Mount Prostatectomy Tissue Analysis"Semantic proximity Read ↗

Assessment of biochemical recurrence of prostate cancer (Review)Semantic proximity Read ↗

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.Semantic proximity Read ↗

Unveiling Prostate Cancer's Molecular Tapestry: Ethnic Disparities and Prognostic Insights from Whole-Mount Prostatectomy Tissue AnalysisSemantic proximity Read ↗

Counting alleles in single lesions of prostate tumors from ethnically diverse patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.